Considering that there is a significant association between endothelial dysfunction and insulin resistance, insulin sensitizers are anticipated to ameliorate endothelial function through restoring PI3-kinase/Akt/eNOS pathway and increasing NO production. This evidence concerns the gene INS and Insulin resistance.